News - MedTech

£203m takeover at life science software firm Instem

The board of life science software firm Instem plc has accepted a £203 million takeover approach. ...

PayPal founder backs London’s Lindus Health

London and US-based startup Lindus Health has completed a £14 million Series A round. The fundin...

Dendritic cell vaccines in cancer treatment

Dendritic cell treatment is a type of сancer immunotherapy that uses "lab-trained" immune cells to ...

Life sciences company raises £4m

Cytemos, an Edinburgh-based life science company that has developed a proprietary new approach to a...

Founder returns as Aptamer Group restructures

The founder of Aptamer Group plc has returned to the company’s board after the struggling firm, wh...

Liverpool City Region is UK’s second Investment Zone

The government has launched a second Investment Zone in Liverpool focused on life sciences. An in...

Entia prepares to launch cancer therapy monitoring platform

Entia has raised £16 million in Series A financing to fund its remote patient monitoring solution f...

OrganOx raises £25m ahead of future IPO

OrganOx, the medical technology company behind metra - an automated device for liver transplantation...

£46m boost for AI MedTech Causaly

Causaly, an AI platform for biomedical research, has closed a £46 million round of Series B funding...

£54m to help MedTech fight degenerative eye diseases

Tenpoint Therapeutics has raised £54 million Series A funding to develop breakthrough regenerative ...

uMed targets United States after raising £9.8m

Health and research technology company uMed has raised £9.8 million in its latest funding round. ...

Upfront Diagnostics develops ‘world-first’ stroke test

Upfront Diagnostics, a healthcare company looking to revolutionise stroke diagnosis, has announced a...

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.